Literature DB >> 26221336

An special epithelial staining agents: folic acid receptor-mediated diagnosis (FRD) effectively and conveniently screen patients with cervical cancer.

Meng-Han Lu1, Ling-Yun Hu1, Xin-Xin Du1, Min Yang1, Wei-Yi Zhang1, Ke Huang1, Li-An Li1, Shu-Fang Jiang1, Ya-Li Li1.   

Abstract

High-quality screening with cytology has markedly reduced mortality from cervical cancer. However, it needs experienced pathologists to review and make the final decisions. We have developed folic acid receptor-mediated diagnosis (FRD) kits to effectively and conveniently screen patients with cervical cancer. We conduct present study aim to assess clinical significances of FRD in screening cervical cancer. A total of 169 patients were enrolled at Chinese People's liberation Army (PLA) general hospital. We compared diagnostic significances of FRD with thinprep cytology test (TCT). Meanwhile, colposcopy was also performed to confirm any lesion suspicious for cervical cancer. The sensitivity and specificity of FRD were 71.93% and 66.07% in diagnosis cervical cancer, respectively. Meanwhile, the positive predictive values (PPV), negative predictive values (NPV), Youden index were 51.90%, 82.22%, 0.38, respectively. On the other hand, the sensitivity and specificity of TCT in diagnosis cervical cancer were 73.68% and 61.61% respectively. PPV, NPV and Youden index for TCT were 49.41%, 82.14% and 0.35 respectively. Overall, FRD have high values of sensitivity, specificity and Youden index. However, this difference failed to statistical significance. FRD have comparable diagnostic significance with TCT. Therefore, FRD might serve as one effective method to screen cervical cancer. Especially for those patients living in remote regions of China, where cytology was unavailable.

Entities:  

Keywords:  Cervical lesion; folate receptor; folic acid receptor-mediated diagnosis

Year:  2015        PMID: 26221336      PMCID: PMC4509281     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

Review 1.  Cervical cancer screening: on the way to a shift from cytology to full molecular screening.

Authors:  M G Dijkstra; P J F Snijders; M Arbyn; D C Rijkaart; J Berkhof; C J L M Meijer
Journal:  Ann Oncol       Date:  2014-01-19       Impact factor: 32.976

2.  Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma.

Authors:  Syed Sultan Beevi; Muzib Hassanal Rasheed; Arumugam Geetha
Journal:  Clin Chim Acta       Date:  2006-06-29       Impact factor: 3.786

3.  Targeting cancer cells with folic acid-iminoboronate fluorescent conjugates.

Authors:  Pedro M S D Cal; Raquel F M Frade; Vijay Chudasama; Carlos Cordeiro; Stephen Caddick; Pedro M P Gois
Journal:  Chem Commun (Camb)       Date:  2013-11-21       Impact factor: 6.222

Review 4.  Targeted drug delivery via the folate receptor.

Authors:  J Sudimack; R J Lee
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

5.  Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

Authors:  Nikki Parker; Mary Jo Turk; Elaine Westrick; Jeffrey D Lewis; Philip S Low; Christopher P Leamon
Journal:  Anal Biochem       Date:  2005-03-15       Impact factor: 3.365

6.  Using HPV prevalence to predict cervical cancer incidence.

Authors:  Monisha Sharma; Laia Bruni; Mireia Diaz; Xavier Castellsagué; Silvia de Sanjosé; F Xavier Bosch; Jane J Kim
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

7.  Oxidative stress and antioxidant status in cervical cancer patients.

Authors:  M Smita K Naidu; A N Suryakar; Sanjay C Swami; R V Katkam; K M Kumbar
Journal:  Indian J Clin Biochem       Date:  2007-09

8.  Folic acid modified gelatine coated quantum dots as potential reagents for in vitro cancer diagnostics.

Authors:  Valérie A Gérard; Ciaran M Maguire; Despina Bazou; Yurii K Gun'ko
Journal:  J Nanobiotechnology       Date:  2011-11-10       Impact factor: 10.435

9.  Detection and pathological value of papillomavirus DNA and p16INK4A and p53 protein expression in cervical intraepithelial neoplasia.

Authors:  Jingbo Wu; Xiao-Jing Li; Wei Zhu; Xiu-Ping Liu
Journal:  Oncol Lett       Date:  2014-01-14       Impact factor: 2.967

10.  Ultrabright fluorescent mesoporous silica nanoparticles for prescreening of cervical cancer.

Authors:  Shajesh Palantavida; Nataliia V Guz; C D Woodworth; I Sokolov
Journal:  Nanomedicine       Date:  2013-05-09       Impact factor: 5.307

View more
  1 in total

1.  Effectiveness of novel folate receptor-mediated staining solution detection (FRD) for cervical cancer screening.

Authors:  Yuping Dai; Lirong Wang; Donghong Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.